Article

What the Medicare Plans Mean to You

President Obama and his Republican challengers, Mitt Romney and Paul Ryan, have very different plans for Medicare, the popular government health insurance for seniors (and some people with disabilities). Obama’s Affordable Care Act tweaks it a bit; Romney and Ryan hope to overhaul it, although many details are unclear. How the plans would affect you depends on your current age.

Read the full story: http://tinyurl.com/92fcnyb

Source: The Washington Post

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Kenny Cole, MD
Dr Johnie Rose
Joseph Saseen, PharmD
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Related Content
Hospital and ED use were similar at the individual and neighborhood levels, but the use of outpatient services differed. | Image credit: Spiroview Inc - stock.adobe.com
April 15th 2025

Individual, Neighborhood-Level Social Risk Indicators Provide Distinct Health Care Use Insights

Rose McNulty
While findings around hospital and emergency department use were similar at the individual and neighborhood levels, the use of outpatient services differed.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Pharmacy online_evso - adobe.stock.com
April 15th 2025

SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps

Giuliana Grossi
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Managed Care Cast Presents: Unlocking the Potential of CGM Technology
April 10th 2025

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

Laura Joszt, MA
A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.
Tirzepatide | Image Credit: © luchschenF-stock.adobe.com
April 14th 2025

Tirzepatide Surges, Overtakes Older Drugs in Diabetes, Obesity Care

Maggie L. Shaw
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.
Center on Health Equity and Access
April 14th 2025

Health Equity & Access Weekly Roundup: April 14, 2025

Giuliana Grossi
From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo